Athena Countouriotis

Affiliations

  • Director at Iovance Biotherapeutics Inc. (IOVA), 2025-06-17
  • at Passage Bio Inc. (PASG), 2025-05-30
  • Director at Biomarin Pharmaceutical Inc (BMRN), 2025-05-22
  • President & Ceo at Turning Point Therapeutics Inc. (TPTX), 2022-08-17
  • Director at Trovagene Inc. (TROV), 2019-06-24
  • Svp, Chief Medical Officer at Adverum Biotechnologies Inc. (ADVM), 2018-02-21
  • Svp And Chief Medical Officer at Halozyme Therapeutics Inc (HALO), 2017-02-24
  • Chief Medical Officer at Ambit Biosciences Corp (AMBI), 2014-11-12
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TPTX $60.00 4,166 $249,960.00 26,872 2020-05-21 Filing
PASG $14.98 10,000 $149,750.00 18,900 2020-03-24 Filing
PASG $18.00 8,900 $160,200.00 8,900 2020-03-03 Filing
TPTX $45.00 10,000 $450,000.00 22,000 2019-09-10 Filing
TPTX $18.00 12,000 $216,000.00 12,000 2019-04-22 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TPTX $36.30 2,971 $107,847.30 47,930 2022-02-09 Filing
TPTX $138.55 3,052 $422,854.60 50,195 2021-02-11 Filing
TPTX $137.66 1,571 $216,263.86 53,247 2021-02-11 Filing
TPTX $136.45 4,319 $589,327.55 54,818 2021-02-11 Filing
TPTX $138.19 433 $59,836.27 50,195 2021-02-10 Filing